1086063-19-5Relevant articles and documents
Discovery of 3,3′-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection
Shi, Weihua,Jiang, Zhigan,He, Haiying,Xiao, Fubiao,Lin, Fusen,Sun, Ya,Hou, Lijuan,Shen, Liang,Han, Lixia,Zeng, Minggao,Lai, Kunmin,Gu, Zhengxian,Chen, Xinsheng,Zhao, Tao,Guo, Li,Yang, Chun,Li, Jian,Chen, Shuhui
supporting information, p. 94 - 97 (2018/02/19)
A new series of 3,3′-spirocyclic-2-oxo-indoline derivatives was synthesized and evaluated against respiratory syncytial virus (RSV) in a cell-based assay and animal model. Extensive structure-activity relationship study led to a lead compound 14h, which e
TRICYCLIC SPIROCYCLE DERIVATIVES AND METHODS OF USE
-
Page/Page column 28-29, (2011/07/29)
The present invention relates to novel Tricyclic Spirocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Spirocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or aired fasting glucose.